Changzheng J. Du

Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications

Inactivation of PRMT5 by PARP Inhibitors Confers High Susceptibility in MTAP-Deficient Cancers.

Inactivation of PRMT5 by PARP Inhibitors Confers High Susceptibility in MTAP-Deficient Cancers.

Journal: Cancers
Published: March 12, 2026

Chromatin unwinding state for in situ identification and lineage tracing of circulating tumor cells.

Chromatin unwinding state for in situ identification and lineage tracing of circulating tumor cells.

Journal: iMeta
Published: February 02, 2026

Prognostic significance of lymph node-related indices and a novel nomogram for rectal cancer patients with synchronous liver metastases after the preoperative chemoradiotherapy: a population-based study.

Prognostic significance of lymph node-related indices and a novel nomogram for rectal cancer patients with synchronous liver metastases after the preoperative chemoradiotherapy: a population-based study.

Journal: Translational cancer research
Published: September 15, 2025

Epigenomic modifications define chromatin states to regulate cell-free DNA fragmentomics.

Epigenomic modifications define chromatin states to regulate cell-free DNA fragmentomics.

Journal: Nature communications
Published: August 05, 2025

Cancer-Like Fragmentomic Characteristics of Somatic Variants in Cell-Free DNA.

Cancer-Like Fragmentomic Characteristics of Somatic Variants in Cell-Free DNA.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 04, 2025

Publisher Correction: Proteasome inhibition induces DNA methylation alteration by attenuating the synthesis of DNA methyltransferase 1 and 3B in colorectal cancer.

Publisher Correction: Proteasome inhibition induces DNA methylation alteration by attenuating the synthesis of DNA methyltransferase 1 and 3B in colorectal cancer.

Journal: Scientific reports
Published: April 15, 2025

Oncometabolite 5-IP7 inhibits inositol 5-phosphatase to license E-cadherin endocytosis.

Oncometabolite 5-IP7 inhibits inositol 5-phosphatase to license E-cadherin endocytosis.

Journal: Nature chemical biology
Published: January 24, 2025

The expression of PRMT5 is associated with postoperative chemotherapeutic outcome in colon cancer.

The expression of PRMT5 is associated with postoperative chemotherapeutic outcome in colon cancer.

Journal: BMC cancer
Published: December 22, 2024

The pronounced cytotoxic effects of chimeric antigen receptor T cells targeting B7-H3 in organoids and liver xenografts derived from colorectal cancer patients.

The pronounced cytotoxic effects of chimeric antigen receptor T cells targeting B7-H3 in organoids and liver xenografts derived from colorectal cancer patients.

Journal: British journal of cancer
Published: October 16, 2024

Proteasome inhibition induces DNA methylation alteration by attenuating the synthesis of DNA methyltransferase 1 and 3B in colorectal cancer.

Proteasome inhibition induces DNA methylation alteration by attenuating the synthesis of DNA methyltransferase 1 and 3B in colorectal cancer.

Journal: Scientific reports
Published: September 29, 2024

The splicing factor SRRM2 modulates two S6K kinases to promote colorectal cancer growth.

The splicing factor SRRM2 modulates two S6K kinases to promote colorectal cancer growth.

Journal: Oncogene
Published: September 27, 2024

CPEB1 Controls NRF2 Proteostasis and Ferroptosis Susceptibility in Pancreatic Cancer.

CPEB1 Controls NRF2 Proteostasis and Ferroptosis Susceptibility in Pancreatic Cancer.

Journal: International journal of biological sciences
Published: March 05, 2024
Showing 1-12 of 41

Last Updated: 09/26/2026